Alnylam Pharmaceuticals, Inc.Cambridge, MA, United States (NASDAQ (GM): ALNY)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Alnylam Financial Forecast

In-Depth Earnings Estimates

Current Quarter
Feb 08
Next Quarter
Mar 09
Current Year
Feb 08
Next Year
Feb 09
Average Estimate ($0.13) ($0.12) ($0.51) ($0.75)
Number of Analysts 7 1 7 6
High Estimate ($0.03) ($0.12) ($0.34) ($0.25)
Low Estimate ($0.27) ($0.12) ($0.69) ($1.27)
Year Ago EPS $0.04 ($0.03) ($1.86) ($0.51)
Growth Rate (432)% (300.00)% 72.73% (48.54)%
Consensus Recommendation: Hold
Interactive Data

Market Data provided by Interactive Data Managed Solutions.
Earnings Data provided by Zacks.